{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:18:18Z","timestamp":1747196298962,"version":"3.40.5"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Caffeine is available in an ampoule, used via parenteral and enteral routes in preterm neonates to treat apnea of prematurity (AOP) in neonates of gestational age \u2265 35\u201340 weeks. A longer duration of therapy has a higher risk of medication non-adherence due to higher costs and inappropriate dosage forms. Pharmaceutically compounded oral caffeine (PCC) could be an appropriate alternate dosage form. The researchers aimed to determine the impact of PCC on medication-related factors influencing medication adherence (MA) and the frequency of hospital readmission with apnea (HRA) in preterm neonates.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We conducted a single-center quasi-experimental study for this quality improvement project using PCC among the preterm neonates admitted in a tertiary care level-III NICU at the Aga Khan University Hospital Karachi, Pakistan, received caffeine therapy, and survived at discharge. The researchers compared pre-PCC data (April-December 2017) with post-PCC data (April-Dec 2018) each for nine months, with three months intervals (January-March 2018) of PCC formulation and implementation phase. The study was conducted according to the SQUIRE2.0 guidelines. The Data were collated on factors influencing MA, including the cost of therapy, medication refill rates, and parental complaints as primary outcome measures. The Risk factors of HRA were included as secondary outcomes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>After PCC implementation cost of therapy was reduced significantly from Rs. 97000.0 (729.0 USD) to Rs. 24500.0 (185.0 USD) (p&lt;0.001), significantly higher (p&lt;0.001) number of patients completed remaining refills (77.6% pre-phase vs 97.5% post-phase). The number of parental complaints about cost, ampoule usage, medication drawing issue, wastage, inappropriate dosage form, and longer duration of therapy reduced significantly in post-phase. HRA reduced from 25% to 6.6% (p&lt;0.001). Post-implementation of PCC (RR 0.14; 95% CI: 0.07\u20130.27) was a significant independent risk factor for reducing HRA using a multivariate analysis model. Longer duration of caffeine therapy after discharge (RR 1.05; 95% CI: 1.04\u20131.04), those who were born in multiple births (RR 1.15; 95% CI: 1.15\u20131.15), and those who had higher number of siblings were other significant independent risk factors for HRA.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>PCC dispensation in the appropriate dosage form at discharge effectively reduced cost, non-adherence to therapy, and risk of hospital readmissions. This neonatal clinical and compounding pharmacist-led model can be replicated in other resource-limiting setting.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0275655","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T19:03:06Z","timestamp":1668020586000},"page":"e0275655","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of pharmaceutically compounded oral caffeine on the impact of medication adherence and risk of readmission among preterm neonates: A single-center quasi-experimental study"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6287-6898","authenticated-orcid":true,"given":"Gul","family":"Ambreen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Akbar Ali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Muzafar","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Sohail","family":"Salat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2728-6726","authenticated-orcid":true,"given":"Muhammad Shahzad","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kashif","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"issue":"2","key":"pone.0275655.ref001","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.resp.2013.05.026","article-title":"Apnea of prematurity\u2013perfect storm.","volume":"189","author":"JM Di Fiore","year":"2013","journal-title":"Respiratory physiology & neurobiology."},{"issue":"6","key":"pone.0275655.ref002","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0022-3476(81)80038-8","article-title":"The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants","volume":"99","author":"I Murat","year":"1981","journal-title":"The Journal of pediatrics"},{"issue":"3","key":"pone.0275655.ref003","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pediatrneurol.2008.09.017","article-title":"Outcomes for the extremely premature infant: what is new? And where are we going?","volume":"40","author":"CM Robertson","year":"2009","journal-title":"Pediatric neurology"},{"issue":"7","key":"pone.0275655.ref004","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00431-015-2494-8","article-title":"High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial","volume":"174","author":"S Mohammed","year":"2015","journal-title":"European journal of pediatrics"},{"issue":"1","key":"pone.0275655.ref005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jpeds.2010.01.046","article-title":"A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity","volume":"157","author":"JM Di Fiore","year":"2010","journal-title":"The Journal of pediatrics"},{"issue":"3","key":"pone.0275655.ref006","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000329922","article-title":"Intermittent hypoxic episodes in preterm infants: do they matter?","volume":"100","author":"RJ Martin","year":"2011","journal-title":"Neonatology"},{"key":"pone.0275655.ref007","article-title":"Pulmonary diseases in the newborn.","author":"D. Henderson-Smart","year":"1986","journal-title":"Textbook of neonatology Melbourne: Churchill Livingstone."},{"issue":"11","key":"pone.0275655.ref008","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/neo.14-11-e540","article-title":"Pharmacology review: caffeine use in neonates: indications, pharmacokinetics, clinical effects, outcomes.","volume":"14","author":"NR Dobson","year":"2013","journal-title":"NeoReviews"},{"issue":"12","key":"pone.0275655.ref009","article-title":"Methylxanthine treatment for apnoea in preterm infants.","author":"DJ Henderson\u2010Smart","year":"2010","journal-title":"Cochrane Database of Systematic Reviews."},{"issue":"1","key":"pone.0275655.ref010","doi-asserted-by":"crossref","first-page":"e20153757","DOI":"10.1542\/peds.2015-3757","article-title":"Apnea of prematurity","volume":"137","author":"KL Watterberg","year":"2016","journal-title":"Pediatrics"},{"issue":"4","key":"pone.0275655.ref011","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1440-1754.1981.tb01957.x","article-title":"The effect of gestational age on the incidence and duration of recurrent apnoea in newborn babies","volume":"17","author":"D. Henderson\u2010Smart","year":"1981","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"3","key":"pone.0275655.ref012","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1651-2227.2007.00618.x","article-title":"Cardiorespiratory development in extremely preterm infants: vulnerability to infection and persistence of events beyond term\u2010equivalent age","volume":"97","author":"A Hofstetter","year":"2008","journal-title":"Acta Paediatrica"},{"issue":"7475","key":"pone.0275655.ref013","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/bmj.329.7475.1151","article-title":"Reducing length of stay in hospital for very low birthweight infants by involving mothers in a stepdown unit: an experience from Karachi (Pakistan).","volume":"329","author":"ZA Bhutta","year":"2004","journal-title":"bmj"},{"volume-title":"Adherence to long-term therapies: evidence for action:","year":"2003","author":"E Sabat\u00e9","key":"pone.0275655.ref014"},{"issue":"2","key":"pone.0275655.ref015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2337\/diaclin.24.2.71","article-title":"Improving patient adherence","volume":"24","author":"AM Delamater","year":"2006","journal-title":"Clinical diabetes"},{"issue":"4","key":"pone.0275655.ref016","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2337\/diacare.22.4.635","article-title":"Beyond\" compliance\" is\" adherence\". Improving the prospect of diabetes care.","volume":"22","author":"KE Lutfey","year":"1999","journal-title":"Diabetes care"},{"issue":"2","key":"pone.0275655.ref017","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/tcmj.tcmj_177_18","article-title":"Improving the assessment of medication adherence: Challenges and considerations with a focus on low-resource settings","volume":"31","author":"S Basu","year":"2019","journal-title":"Tzu-Chi Medical Journal"},{"issue":"1","key":"pone.0275655.ref018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jcpt.12441","article-title":"A systematic review of factors that influence treatment adherence in paediatric oncology patients","volume":"42","author":"X Goh","year":"2017","journal-title":"Journal of clinical pharmacy and therapeutics"},{"key":"pone.0275655.ref019","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fphar.2013.00091","article-title":"Determinants of patient adherence: a review of systematic reviews.","volume":"4","author":"P Kardas","year":"2013","journal-title":"Frontiers in pharmacology"},{"issue":"7653","key":"pone.0275655.ref020","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/bmj.39553.670231.25","article-title":"Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories","volume":"336","author":"B Vrijens","year":"2008","journal-title":"Bmj"},{"issue":"8","key":"pone.0275655.ref021","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/INF.0b013e31816dd325","article-title":"A systematic review of pediatric adherence to antiretroviral therapy in low-and middle-income countries","volume":"27","author":"RC Vreeman","year":"2008","journal-title":"The Pediatric infectious disease journal"},{"volume-title":"Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?","year":"2020","author":"V Saroha","key":"pone.0275655.ref022"},{"key":"pone.0275655.ref023","unstructured":"Food U, Administration D. Compounding and the FDA: questions and answers. Washington,(DC): Available from: URL: http:\/\/wwwfdagov\/Drugs\/GuidanceComplianceRegulatoryInformation\/PharmacyCompounding\/ucm339764htm Accessed January. 2016;14."},{"issue":"2","key":"pone.0275655.ref024","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11096-011-9496-z","article-title":"Community pharmacy compounding\u2013impact on professional status","volume":"33","author":"JA Giam","year":"2011","journal-title":"International journal of clinical pharmacy"},{"key":"pone.0275655.ref025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.curtheres.2015.08.002","article-title":"Pill properties that cause dysphagia and treatment failure.","volume":"77","author":"J Fields","year":"2015","journal-title":"Current Therapeutic Research"},{"issue":"6","key":"pone.0275655.ref026","first-page":"514","article-title":"Pharmacists\u2019 Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States.","volume":"19","author":"WB Lobb","year":"2015","journal-title":"International journal of pharmaceutical compounding"},{"issue":"5","key":"pone.0275655.ref027","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/children6050066","article-title":"Pediatric compounding pharmacy: taking on the responsibility of providing quality customized prescriptions.","volume":"6","author":"T Heitman","year":"2019","journal-title":"Children"},{"key":"pone.0275655.ref028","first-page":"22","article-title":"Beliefs about the use of extemporaneous compounding for paediatric outpatients among physicians in Yogyakarta, Indonesia","volume":"41","author":"C Wiedyaningsih","year":"2016","journal-title":"Int J Pharm Sci Rev Res"},{"issue":"22","key":"pone.0275655.ref029","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan\u2019s syndrome","volume":"371","author":"RV Lacro","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"pone.0275655.ref030","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2215\/CJN.11111113","article-title":"A randomized, open-label, dose-response study of losartan in hypertensive children","volume":"9","author":"NJ Webb","year":"2014","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"4","key":"pone.0275655.ref031","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research","volume":"27","author":"AK Wagner","year":"2002","journal-title":"Journal of clinical pharmacy and therapeutics"},{"key":"pone.0275655.ref032","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE 2.0: revised publication guidelines from a detailed consensus process standards for quality improvement reporting excellence: revised publication guidelines from a detailed consensus process","volume":"25","author":"G Ogrinc","year":"2016","journal-title":"BMJ Qual Saf"},{"key":"pone.0275655.ref033","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2147\/PPA.S125672","article-title":"Medication adherence as a predictor of 30-day hospital readmissions.","volume":"11","author":"OZ Rosen","year":"2017","journal-title":"Patient preference and adherence."},{"issue":"1","key":"pone.0275655.ref034","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0031-3955(16)34975-6","article-title":"Necrotizing enterocolitis: treatment based on staging criteria.","volume":"33","author":"MC Walsh","year":"1986","journal-title":"Pediatric clinics of North America."},{"key":"pone.0275655.ref035","doi-asserted-by":"crossref","unstructured":"Kienle PCJPT. Compounding nonsterile preparations: USP< 795> and< 800. 2017;23(10):56\u201372.","DOI":"10.1016\/j.ptdy.2017.09.010"},{"issue":"11","key":"pone.0275655.ref036","first-page":"2405","article-title":"Stability of citrated caffeine solutions for injectable and enteral use","volume":"41","author":"MG Eisenberg","year":"1984","journal-title":"American journal of hospital pharmacy"},{"issue":"4","key":"pone.0275655.ref037","first-page":"36","article-title":"Caffeine Citrate 10 mg\/mL Oral Liquid.","volume":"38","author":"LV Allen","year":"2013","journal-title":"US Pharm."},{"key":"pone.0275655.ref038","article-title":"Medication adherence measures: an overview.","volume":"2015","author":"WY Lam","year":"2015","journal-title":"BioMed research international."},{"issue":"2","key":"pone.0275655.ref039","first-page":"177","article-title":"Community pharmacy compounding\u2013impact on professional status.","volume":"33","author":"JA Giam","year":"2011"},{"issue":"3","key":"pone.0275655.ref040","first-page":"240","article-title":"Characterizing specialized compounding in community pharmacies.","volume":"8","author":"JA Giam","year":"2012"},{"issue":"3","key":"pone.0275655.ref041","first-page":"328","article-title":"Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe.","volume":"117","author":"P Minghetti","year":"2014"},{"issue":"1","key":"pone.0275655.ref042","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1331\/JAPhA.2011.09154","article-title":"Selection of a validated scale for measuring medication adherence","volume":"51","author":"SM Lavsa","year":"2011","journal-title":"Journal of the American Pharmacists Association"},{"issue":"2","key":"pone.0275655.ref043","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0738-3991(98)00107-4","article-title":"The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence.","volume":"37","author":"BL Svarstad","year":"1999","journal-title":"Patient education and counseling."},{"issue":"1","key":"pone.0275655.ref044","first-page":"e016982","article-title":"Economic impact of medication non-adherence by disease groups: a systematic review.","volume":"8","author":"RL Cutler","year":"2018"},{"issue":"6","key":"pone.0275655.ref045","first-page":"1861","volume":"73","author":"WJ Yeung","year":"2002","journal-title":"How money matters for young children\u2019s development: Parental investment and family processes"},{"issue":"31_suppl","key":"pone.0275655.ref046","first-page":"26","volume":"90","author":"J Leaver","year":"1997","journal-title":"Home intravenous antibiotic therapy: practical aspects in children"},{"key":"pone.0275655.ref047","unstructured":"Use CfMPfH. Paediatric Committee: Guideline on pharmaceutical development of medicines for paediatric use EMA. CHMP\/QWP\/805880\/2012 Rev. 2. 2013. http:\/\/www.ema.europa.eu\/docs\/en_GB\u2026; 2016."},{"issue":"10","key":"pone.0275655.ref048","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/pharmaceutics11100518","article-title":"Innovations in pediatric drug formulations and administration technologies for low resource settings.","volume":"11","author":"SE Gerrard","year":"2019","journal-title":"Pharmaceutics"},{"issue":"6","key":"pone.0275655.ref049","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012226","article-title":"Interventions to improve adherence to inhaled steroids for asthma","author":"KM Kew","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"volume-title":"Adherence to long-term therapies: evidence for action","year":"2003","author":"WH Organization","key":"pone.0275655.ref050"},{"issue":"2","key":"pone.0275655.ref051","first-page":"124","article-title":"Pharmacists and pediatric medication adherence: Bridging the gap.","volume":"52","author":"S El-Rachidi","year":"2017"},{"issue":"2","key":"pone.0275655.ref052","first-page":"73","article-title":"Improving the assessment of medication adherence: Challenges and considerations with a focus on low-resource settings.","volume":"31","author":"S Basu","year":"2019"},{"issue":"24","key":"pone.0275655.ref053","first-page":"3377","article-title":"Adolescents\u2019 compliance with the use of oral contraceptives.","volume":"257","author":"SJ Emans","year":"1987"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0275655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T19:03:46Z","timestamp":1668020626000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0275655"}},"subtitle":[],"editor":[{"given":"Francesca","family":"Baratta","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":53,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0275655","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2022,11,9]]}}}